Patients with a prior ischemic stroke or transient ischemic attacks are prescribed antiplatelet (aspirin) or anticoagulation (warfarin) agents to reduce the risk of future thromboembolic events. Because these medications increase risk for bleeding, questions remain about whether such patients should continue to take them when undergoing invasive procedures that involve an inherent increased risk of bleeding. The American Academy of Neurology offers some answers in a guideline published online May 28 (http://tinyurl.com/lfkeanp).
Mitka M. Continuing Antithrombotics Advised for Stroke Survivors During Certain Procedures. JAMA. 2013;309(24):2537. doi:10.1001/jama.2013.7698